Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javle

Showing results (141-150 of 343) with videos related to

Pageof 35
Sort By:
Cancer Chemotherapy and Pharmacology|October 27, 2006
Phase I study of weekly DN-101, a new formulation of calcitriol, in patients with cancerTomasz M Beer, Milind M Javle, Christopher W Ryan, et al.
Journal of Hematology & Oncology|May 31, 2018
Randomized, phase I/II study of gemcitabine plus IGF-1R antagonist (MK-0646) versus gemcitabine plus erlotinib with and without MK-0646 for advanced pancreatic adenocarcinomaReham Abdel-Wahab, Gauri R Varadhachary, Priya R Bhosale, et al.
Journal of Hepatology|March 30, 2026
Global patterns of mutational profiles in biliary tract cancerYan Zhu, Jason A Wu, Dengyong Zhang, et al.
Annals of Surgical Oncology|June 22, 2006
Activated Akt and Erk expression and survival after surgery in pancreatic carcinomaKrishdeep S Chadha, Thaer Khoury, Jihnhee Yu, et al.
Investigational New Drugs|May 7, 2013
The addition of erlotinib to gemcitabine and cisplatin does not appear to improve median survival in metastatic pancreatic cancerMohamed A Khalil, Wei Qiao, Peter Carlson, et al.
BMC Cancer|April 21, 2026
Genomic landscape of cholangiocarcinoma in India: ethnic variants and implications for targeted therapyMoushumi Suryavanshi, Vikas Ostwal, Milind Javle, et al.
BMC Cancer|July 16, 2010
Inhibition of the mammalian target of rapamycin (mTOR) in advanced pancreatic cancer: results of two phase II studiesMilind M Javle, Rachna T Shroff, Henry Xiong, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 15, 2016
Biologic mesh spacer placement facilitates safe delivery of dose-intense radiation therapy: A novel treatment option for unresectable liver tumorsH N Ismael, J Denbo, S Cox, et al.
The Oncologist|December 30, 2017
Portomesenteric Venous Stenting for Palliation of Ascites and Variceal Bleeding Caused by Prehepatic Portal HypertensionRahul A Sheth, Sharjeel H Sabir, Philip Parmet, et al.
JCO Global Oncology|December 19, 2025
Genomic Profiling of Indian Gallbladder Carcinoma: Mutational Insights in a High-Incidence PopulationMoushumi Suryavanshi, Vikas Ostwal, Milind M Javle, et al.
Pageof 35

Showing results (141-150 of 343) with videos related to

Sort By:
Pageof 35
Cancer Chemotherapy and Pharmacology|October 27, 2006
Phase I study of weekly DN-101, a new formulation of calcitriol, in patients with cancerTomasz M Beer, Milind M Javle, Christopher W Ryan, et al.
Journal of Hematology & Oncology|May 31, 2018
Randomized, phase I/II study of gemcitabine plus IGF-1R antagonist (MK-0646) versus gemcitabine plus erlotinib with and without MK-0646 for advanced pancreatic adenocarcinomaReham Abdel-Wahab, Gauri R Varadhachary, Priya R Bhosale, et al.
Journal of Hepatology|March 30, 2026
Global patterns of mutational profiles in biliary tract cancerYan Zhu, Jason A Wu, Dengyong Zhang, et al.
Annals of Surgical Oncology|June 22, 2006
Activated Akt and Erk expression and survival after surgery in pancreatic carcinomaKrishdeep S Chadha, Thaer Khoury, Jihnhee Yu, et al.
Investigational New Drugs|May 7, 2013
The addition of erlotinib to gemcitabine and cisplatin does not appear to improve median survival in metastatic pancreatic cancerMohamed A Khalil, Wei Qiao, Peter Carlson, et al.
BMC Cancer|April 21, 2026
Genomic landscape of cholangiocarcinoma in India: ethnic variants and implications for targeted therapyMoushumi Suryavanshi, Vikas Ostwal, Milind Javle, et al.
BMC Cancer|July 16, 2010
Inhibition of the mammalian target of rapamycin (mTOR) in advanced pancreatic cancer: results of two phase II studiesMilind M Javle, Rachna T Shroff, Henry Xiong, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 15, 2016
Biologic mesh spacer placement facilitates safe delivery of dose-intense radiation therapy: A novel treatment option for unresectable liver tumorsH N Ismael, J Denbo, S Cox, et al.
The Oncologist|December 30, 2017
Portomesenteric Venous Stenting for Palliation of Ascites and Variceal Bleeding Caused by Prehepatic Portal HypertensionRahul A Sheth, Sharjeel H Sabir, Philip Parmet, et al.
JCO Global Oncology|December 19, 2025
Genomic Profiling of Indian Gallbladder Carcinoma: Mutational Insights in a High-Incidence PopulationMoushumi Suryavanshi, Vikas Ostwal, Milind M Javle, et al.
Pageof 35